Skip to main content

Alpha Cognition Inc.

ACOG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001655923

In the last 90 days, Alpha Cognition Inc. insiders filed 7 open-market purchases and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $75.7M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Alpha Cognition Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of ACOG: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders2322−1
Shares5.94M6.34M+395.1K (+6.6%)
Value$34.9M$32.4M−$2.46M (−7.0%)

New holders (2)

Institutions that held Alpha Cognition Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to ACOG in Q1 2025
InstitutionSharesValue% of portfolio
AWM Investment Company, Inc.1,095,652$5.79M0.80%
Salem Investment Counselors Inc45,402$229.7K0.01%

Sold out (3)

Institutions that held Alpha Cognition Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of ACOG in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Sio Capital Management, LLC434,700$2.56M
ADAR1 Capital Management, LLC204,348$1.20M
UBS Group AG8,654$51.0K